While Glatopa (and its branded equivalent, Copaxone) doesn't directly suppress the immune system, it can lead to a secondary immunosuppressant response. This means that individuals taking Glatopa may experience increased susceptibility to illnesses and infections.
Here's a breakdown:
-
Direct vs. Indirect Immunosuppression: Glatopa doesn't act as a traditional immunosuppressant medication, such as those used to prevent organ rejection. However, the medication can still cause a secondary immunosuppressant response.
-
Increased Susceptibility: As indicated in the provided reference, while on Glatopa, “a person's immune system is more susceptible to illness and infection.” This highlights the importance of taking precautions to avoid exposure to pathogens.
In essence, the medication's mechanism of action can indirectly weaken the immune system's ability to effectively fight off infections.
